HappeningToo topic
Glimepiride reports
Browse community reports connected to Glimepiride. These reports can show that other people are describing similar experiences, but they do not prove that Glimepiride caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
40 problems
Abdominal Discomfort while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and abdominal discomfort appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and abdominal distension appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and abdominal pain upper appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and abdominal pain appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and acid reflux appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and alopecia appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and anxiety appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and back pain appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and constipation appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and cough appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and decreased appetite appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and dehydration appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and diarrhea appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and dizziness appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and dyspepsia appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and excessive sweating appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and fatigue appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and feeling abnormal appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and headache appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and hypotension appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and insomnia appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and itching appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and malaise appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and muscle spasms appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and muscular weakness appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and myalgia appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and nausea appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and pain appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and peripheral swelling appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and rash appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and shortness of breath appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and skin redness appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and sleepiness appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and tingling or pins and needles appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and tremor appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and vision blurred appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and vomiting appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and weakness appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and weight decreased appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Glimepiride
FDA FAERS contains adverse-event reports in which Glimepiride and weight increased appear together. This does not establish that Glimepiride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →